Kenney CT, Marraffini LA.  2023.  Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence.. Nucleic Acids Res. 51(14):7438-7450.

Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, Xu C, Wang Q, Soh C-L, Yang D et al..  2019.  Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation.. Nat Genet. 51(6):999-1010.

Nussenzweig PM, Marraffini LA.  2018.  Viral Teamwork Pushes CRISPR to the Breaking Point.. Cell. 174(4):772-774.

Verma N, Zhu Z, Huangfu D.  2017.  CRISPR/Cas-Mediated Knockin in Human Pluripotent Stem Cells.. Methods Mol Biol. 1513:119-140.

Perez AR, Pritykin Y, Vidigal JA, Chhangawala S, Zamparo L, Leslie CS, Ventura A.  2017.  GuideScan software for improved single and paired CRISPR guide RNA design.. Nat Biotechnol. 35(4):347-349.

O'Rourke KP, Loizou E, Livshits G, Schatoff EM, Baslan T, Manchado E, Simon J, Romesser PB, Leach B, Han T et al..  2017.  Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.. Nat Biotechnol. 35(6):577-582.

Zhu Z, Verma N, González F, Shi Z-D, Huangfu D.  2015.  A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.. Stem Cell Reports. 4(6):1103-11.

Dow LE, Fisher J, O'Rourke KP, Muley A, Kastenhuber ER, Livshits G, Tschaharganeh DF, Socci ND, Lowe SW.  2015.  Inducible in vivo genome editing with CRISPR-Cas9.. Nat Biotechnol. 33(4):390-394.

González F, Zhu Z, Shi Z-D, Lelli K, Verma N, Li QV, Huangfu D.  2014.  An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.. Cell Stem Cell. 15(2):215-226.